Disruption of Circadian Clocks Promotes Progression of Alzheimer’s Disease in Diabetic Mice

被引:0
|
作者
Jiaojiao Huang
Xuemin Peng
Rongping Fan
Kun Dong
Xiaoli Shi
Shujun Zhang
Xuefeng Yu
Yan Yang
机构
[1] Huazhong University of Science and Technology,Department of Endocrinology, Tongji Hospital, Tongji Medical College
[2] Branch of National Clinical Research Center for Metabolic Diseases,undefined
来源
Molecular Neurobiology | 2021年 / 58卷
关键词
Circadian rhythms; Light; Alzheimer’s disease; Type 2 diabetes mellitus;
D O I
暂无
中图分类号
学科分类号
摘要
The circadian clock is an endogenous system designed to anticipate and adapt to daily changes in the environment. Alzheimer’s disease (AD) is a progressive neurodegenerative disease, which is more prevalent in patients with type 2 diabetes mellitus (T2DM). However, the effects of circadian disruption on mental and physical health for T2DM patients are not yet fully understood, even though circadian disruption has been confirmed to promote the progression of AD in population. By housing db/db mice on a disrupted (a 6:18 light/dark cycle) circadian rhythm, we assessed the circadian gene expression, body weight, cognitive ability, and AD-related pathophysiology. Our results indicated that housing in these conditions led to disrupted diurnal circadian rhythms in the hippocampus of db/db mice and contributed to their weight gain. In the brain, the circadian-disrupted db/db mice showed a decreased cognitive ability and an increased hyperphosphorylation of tau protein, even though no difference was found in amyloid protein (Aβ) plaque deposition. We also found that the hyperphosphorylated tau protein exhibited more disruptive daily oscillations in db/db mice hippocampus under the 6:18 light/dark cycle. Circadian alterations could promote the development of AD in T2DM.
引用
收藏
页码:4404 / 4412
页数:8
相关论文
共 50 条
  • [41] Circadian rhythms and sundowning in Alzheimer's disease
    Volicer, L
    Harper, DG
    Satlin, A
    NEUROLOGY, 1999, 52 (06) : A123 - A123
  • [42] Circadian Rhythm of Melatonin and Alzheimer's Disease
    Zhou Jiang-Ning
    Liu Ya-Jing
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2012, 39 (08) : 796 - 803
  • [43] Circadian fragmentation: a harbinger of Alzheimer's disease?
    Musiek, Erik S.
    LANCET HEALTHY LONGEVITY, 2020, 1 (03): : E90 - E91
  • [44] Sleep Disorders and Circadian Disruption in Huntington's Disease
    Saade-Lemus, Sandra
    Videnovic, Aleksandar
    JOURNAL OF HUNTINGTONS DISEASE, 2023, 12 (02) : 121 - 131
  • [45] Assessing disease progression in Alzheimer's disease
    Katzourou, I.
    Holmans, P.
    Williams, J.
    Escott-Price, V.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 31 : S61 - S62
  • [46] Disruption of Calcium Homeostasis in Alzheimer's Disease
    Korol', T. Yu.
    Korol', S. V.
    Kostyuk, E. P.
    Kostyuk, P. G.
    NEUROPHYSIOLOGY, 2008, 40 (5-6) : 385 - 392
  • [47] Disruption of Calcium Homeostasis in Alzheimer’s Disease
    T. Yu. Korol’
    S. V. Korol’
    E. P. Kostyuk
    P. G. Kostyuk
    Neurophysiology, 2008, 40 : 385 - 392
  • [48] Disruption of zinc homeostasis in Alzheimer's disease
    Robertson, JD
    Crafford, AM
    Markesbery, WR
    Lovell, MA
    NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS, 2002, 189 : 454 - 458
  • [49] Predicting progression of Alzheimer's disease
    Rachelle S Doody
    Valory Pavlik
    Paul Massman
    Susan Rountree
    Eveleen Darby
    Wenyaw Chan
    Alzheimer's Research & Therapy, 2
  • [50] Metabolome in progression to Alzheimer's disease
    M Orešič
    T Hyötyläinen
    S-K Herukka
    M Sysi-Aho
    I Mattila
    T Seppänan-Laakso
    V Julkunen
    P V Gopalacharyulu
    M Hallikainen
    J Koikkalainen
    M Kivipelto
    S Helisalmi
    J Lötjönen
    H Soininen
    Translational Psychiatry, 2011, 1 : e57 - e57